News
PerkinElmer to Acquire Oxford Immunotec Global PLC
- Details

CARISMA Therapeutics Completes Series B Funding for $47 Million to Advance Development of Novel CAR-Macrophage Immunotherapies
- Details

Adrenomed Supervisory Board appoints Dr. Wolfgang Baiker as CEO
- Details
